SCHEMBL16923652

SCHEMBL16923652

OCC1(NCl)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20644930 0.97 DPP4 (0.34)
SCHEMBL21834946 0.88
SCHEMBL422018 0.72
SCHEMBL1488095 0.72
SCHEMBL14395107 0.72
SCHEMBL5608346 0.72
SCHEMBL1488027 0.70 DPP4 (0.34)
SCHEMBL15899113 0.70 DPP4 (0.34)
SCHEMBL420711 0.70 DPP4 (0.34)
SCHEMBL4441754 0.70 DPP4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220024854-A1 SALTS OF DIAMINOACETALS AND DIAMINOKETALS AND THEIR SYNTHESIS, AND THEIR TRANSFORMATIONS TO DIAMINOACETALS AND DIAMINOKETALS ADITYA BIRLA CHEMICALS (USA) LLC 2022-01-27 US disclosed
US-11124473-B2 Salts of diaminoacetals and diaminoketals and their synthesis, and their transformations to diaminoacetals and diaminoketals ADITYA BIRLA CHEMICALS (USA) LLC (US) 2021-09-21 US disclosed
US-20190016667-A1 SALTS OF DIAMINOACETALS AND DIAMINOKETALS AND THEIR SYNTHESIS, AND THEIR TRANSFORMATIONS TO DIAMINOACETALS AND DIAMINOKETALS ADITYA BIRLA CHEMICALS (USA), INC. 2019-01-17 US disclosed
US-9771378-B2 Fused morpholinopyrimidines and methods of use thereof DENALI THERAPEUTICS, INC. (US) 2017-09-26 US disclosed
US-20170044182-A1 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF FORUM PHARMACEUTICALS INC. 2017-02-16 US disclosed
WO-2015109109-A1 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF FORUM PHARMACEUTICALS INC. (US) 2015-07-23 WO disclosed